Drug Database
Back to search

Belgium· BE-AMP-SAM286754-00

Rotarix

A rotavirus, lebend abgeschwächt product containing human rotavirus, registered in Belgium by GlaxoSmithKline Biologicals. The same ATC class is registered in 11 of our 19 countries.

ATC J07BH01

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedRotarixATCJ07BH01REGISTER NO.BE-AMP-SAM286754-00PACKS LISTED0CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about human rotavirusAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Rotavirus, lebend abgeschwächt is registered in 11 of 19 countries.

Countries holding a registration under ATC J07BH01 (rotavirus, lebend abgeschwächt), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 7 of them publish a price we can compare per daily dose
Search rotavirus, lebend abgeschwächt products by name

Rotavirus, lebend abgeschwächt · ATC J07BH01

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Human Rotavirus
Manufacturer
GlaxoSmithKline Biologicals
Country
Belgium (BE)
ATC code
J07BH01
ATC class
Rotavirus, lebend abgeschwächt
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under J07BH01

Rotavirus, lebend abgeschwächt, as other registers publish it.

All rotavirus, lebend abgeschwächt products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/6c7bfbcd-7d05-4265-8601-878507d84324
GET /v1/drugs/6c7bfbcd-7d05-4265-8601-878507d84324?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Powder and solvent for oral suspension",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Rotarix",
  "name_fr": "Rotarix",
  "name_nl": "Rotarix",
  "amp_code": "SAM286754-00",
  "strengths": null,
  "pack_count": 4,
  "substances": [
    "Human Rotavirus"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Rota Virus, Live Attenuated",
  "authorisation_numbers": [
    "EU/1/05/330/001",
    "EU/1/05/330/004",
    "EU/1/05/330/003",
    "EU/1/05/330/002"
  ]
}
API referenceMCP serverPlans

See everything about rotavirus, lebend abgeschwächt.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console